Vincenza C.
- Country
- Italy
- Department
- Oncologia Medica e Terapia Biomolecolare
Research Overview
- "APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN".
- Avelumab Maintenance Versus Best Supportive Care After Second-Line Platinum-Based Chemotherapy in Metastatic Urothelial Carcinoma (AVESEC Trial)
- Phase III Randomized Trial of Docetaxel plus Apalutamide Intensification in Metastatic Hormone-Sensitive Prostate Cancer with Inadequate PSA Response
Data & Insights
Has run more than one trial at 110 of 304 partner sites.
Specializations
Advanced Prostate Cancer Management
This investigator specializes in treating metastatic prostate cancer, with particular emphasis on developing therapeutic strategies for patients with castration-resistant prostate cancer (CRPC).
- Novel therapeutic combinations with docetaxel
- PARP inhibitor treatment sequencing
- Management of treatment resistance
The investigator explores innovative treatment approaches combining established chemotherapy protocols with targeted therapies.
Precision Radiation Therapy
Focus on integrating stereotactic body radiation therapy with hormone therapy for oligometastatic prostate cancer, investigating novel treatment combinations to enhance patient outcomes.
- Targeted radiation approaches
- Hormone-sensitive disease management
- Multimodal treatment strategies
The research encompasses comprehensive treatment approaches combining systemic and local therapies.
Personalized Treatment Approaches
Expertise in developing tailored therapeutic strategies for different patient populations, including frail patients with de novo metastatic prostate cancer.
- Androgen deprivation therapy optimization
- Novel therapeutic agents evaluation
- Patient-specific treatment selection
The investigator evaluates innovative treatment approaches while considering individual patient characteristics and needs.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.